Federal award (DEFINITIVE CONTRACT, fiscal year 2024)
Recipient: CONTINUITY BIOSCIENCES, LLC
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2025-09-05 to 2027-09-04
Current total value of award: $2995581
Description: DIRECT TO PHASE II SBIR CONCEPT AWARD FOR NOVEL IONTOPHORETIC DRUG DELIVERY DEVICE FOR LOCAL AND EFFECTIVE TREATMENT OF ORAL CANCER